A Mouse Cannabinoid-Withdrawal Study Found Unequal Changes Across Brain Genes
Reducing withdrawal-related behavior does not mean every measured biological change has been reversed. A mouse study of pregabalin and topiramate reported improvements in several withdrawal measures, alongside a gene-expression change that neither treatment corrected.
The withdrawal model used a synthetic agonist
Mice received repeated CP55,940, an experimental cannabinoid receptor agonist, before treatment stopped. Researchers measured motor behavior, physical signs and anxiety-like behavior during spontaneous withdrawal. The experiment did not involve people stopping ordinary cannabis products.
Behavior and transcription were separate outcomes
The supplied abstract reports increased motor activity and anxiety-like behavior after cessation. Pregabalin or topiramate reduced these behavioral findings. Withdrawal also changed expression of tyrosine hydroxylase, CB1 receptor and mu-opioid receptor genes in specified brain regions.
Some molecular effects persisted
Both medications countered the reported tyrosine-hydroxylase decrease and CB1-expression increase. Neither altered the withdrawal-associated mu-opioid receptor gene-expression finding. That mixed pattern is more informative than saying either medication normalized the brain.
Gene transcription is not a direct measure of protein abundance, receptor activity or a patient's clinical recovery. Anxiety-like behavior in mice is also an experimental outcome rather than a human diagnostic interview. The study provides a rationale for further investigation, not evidence to prescribe either drug for cannabis withdrawal. Treatment claims require human evidence about benefit, adverse effects, dosing and the circumstances in which a medication is used.
Related: interpreting cannabis tolerance claims.
Research cited
Aracil-Fernández A; Almela P; Manzanares J. Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice. Addiction biology (2013). doi:10.1111/j.1369-1600.2011.00406.x. Findings discussed from the study abstract.
